PRINCIPAL FINANCIAL GROUP INC
Position in PTGX — Protagonist Therapeutics, Inc
CIK 1126328
DES MOINES, IA
Position in PTGX
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$47,225,415
+$8,456,977 QoQ
Shares Held
385,262
+4.7% QoQ
Ownership
0.595%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#34
of 341 holders
Holding Since
Mar 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRINCIPAL FINANCIAL GROUP INC holds $1,852,088,599 across 105 Biotechnology names. PTGX ranks #10 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
873,502 | $232,980,453 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
389,511 | $193,481,798 | |
| 3 | CYTK |
Cytokinetics Inc
|
1,311,664 | $111,740,655 | |
| 4 | GPCR |
Structure Therapeutics Inc.
|
1,752,753 | $94,070,253 | |
| 5 | INSM |
INSMED Inc
|
856,126 | $91,280,154 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
332,642 | $81,420,782 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
1,024,423 | $76,299,024 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
121,053 | $75,481,386 |
All Filings in PTGX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $47,225,415 | 385,262 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $38,768,438 | 367,822 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $30,388,380 | 347,932 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $21,662,025 | 326,088 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $18,246,505 | 330,134 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $16,785,514 | 347,095 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $13,039,427 | 337,809 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $14,437,440 | 320,832 | Shares | Defined | 2024-12-19 | |
| 2024-06-30 | $347,470 | 10,028 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $415,694 | 14,369 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $330,856 | 14,429 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $249,715 | 14,971 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $384,000 | 13,903 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $311,029 | 13,523 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $128,060 | 11,738 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $87,241 | 10,349 | Shares | Defined | 2022-11-09 | |
| 2021-12-31 | $260,159 | 7,607 | Shares | Defined | 2022-02-09 | |
| 2021-06-30 | $742,314 | 16,540 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $211,758 | 8,176 | Shares | Defined | 2021-05-10 | |
| No filing history on record for this holder in this stock. | ||||||